Steven Gillis insider trades

Open-market stock purchases and sales by Steven Gillis, Director at Takeda Pharmaceutical Co Ltd, from SEC Form 4 filings since Oct 28, 2010.

Recent trades

DateStockTradeValue
Jul 10, 2026TAK Takeda Pharmaceutical Co LtdSold (not open market)$5.7M
Jul 1, 2026TAK Takeda Pharmaceutical Co LtdBought (not open market)—
Jul 1, 2026TAK Takeda Pharmaceutical Co LtdBought (not open market)—

Companies traded

  • TAK Takeda Pharmaceutical Co Ltd: other filings, last Jul 10, 2026
  • VBIV VBI Vaccines Inc/BC: 3 buys, last Jul 27, 2023
  • FIXX Homology Medicines, Inc: other filings, last Jun 14, 2023
  • CDAK Codiak BioSciences, Inc: 2 buys, last Feb 16, 2023
  • PULM Pulmatrix, Inc: 2 buys, last Aug 28, 2020
  • PZRX Phaserx, Inc: 1 buy, 2 sales, last May 25, 2017
  • BLUE bluebird bio, Inc: 7 sales, last Jul 28, 2015
  • TRBN Trubion Pharmaceuticals, Inc: other filings, last Oct 28, 2010

Get free alerts when Steven Gillis files a new trade →